The use of drotrecogin alfa (activated) in a patient with recent orthotopic liver transplant

Anaesthesia

Volumn 62, Issue 3, 2007, Pages 282-285

  Browne, E ^a   Cressey, D M ^a   Agarwal, K ^b   Cosgrove, Joe F ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DROTRECOGIN; HYPERTENSIVE AGENT; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; NORADRENALIN; STEROID; ANTIINFECTIVE AGENT; PROTEIN C; RECOMBINANT PROTEIN;

ABSENCE OF SIDE EFFECTS; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; APACHE; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CASE REPORT; COMORBIDITY; CONTINUOUS HEMOFILTRATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EMPHYSEMA; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT VERSUS HOST REACTION; HEART ARREST; HEPATIC ENCEPHALOPATHY; HUMAN; INOTROPISM; INTENSIVE CARE; ISCHEMIC HEART DISEASE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; POSTOPERATIVE PERIOD; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RISK BENEFIT ANALYSIS; SEPSIS; SPUTUM CULTURE; STEROID THERAPY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT;

ANTI-INFECTIVE AGENTS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROTEIN C; RECOMBINANT PROTEINS; RISK ASSESSMENT; SEPSIS;

EID: 34047141552     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.04952.x     Document Type: Article

References (8)

1. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human Activated Protein C for severe sepsis. New England Journal of Medicine 2001; 344: 699-07.
2. Lorente JA, Garcia-Frade LJ, Landin L, et al. Time course of haemostatic abnormalities in sepsis and its relation to outcome. Chest 1993; 103: 1536-42.
3. Boldt J, Papsdorf M, Rothe A, Kumle B, Piper S. Changes of the haemostatic network in critically ill patients - Is there a difference between sepsis, trauma and neurosurgery patients? Critical Care Medicine 2000; 28: 445-50.
4. Fourrier F, Chopin C, Goudemande J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 1992; 101: 816-22.
5. Singh N, Gayowski T, Wagener MM, Marino IR. Bloodstream infections in liver transplant recipients receiving tacrolimus. Clinical Transplantation 1997; 11: 275-81.
6. Singh N, Paterson D, Gayowski T, Wagener MM, Marino IR. Predicting bacteraemia and bacteraemic mortality in liver transplant recipients. Liver Transplantation 2000; 6: 54-61.
7. Kulkarni S, Naureckas E, Cronin D. Solid organ transplant recipients treated with drotrecogin alfa (activated) for severe sepsis. Transplantation 2003; 75: 899-901.
8. General Medical Council. Guidance Library: Prescribing medications - situations requiring special consideration. http://WWW.Gmc-Uk.Org/ Guidance/Library [accessed 16 March 2006].